Showing results (1-10 of 673) with videos related to
Sort By:
Pageof 68
HIV Clinical Trials|August 21, 2002
Safety and tolerance of efavirenz in different antiretroviral regimens: results from a national multicenter prospective study in 1,033 HIV-infected patientsJosé A Pérez-MolinaHIV Clinical Trials|October 31, 2002
Lamivudine 300 mg QD versus continued lamivudine 150 mg BID with stavudine and a protease inhibitor in suppressed patientsMichael G Sension, Nicholaos C Bellos, Judy Johnson, et al.HIV Clinical Trials|October 31, 2002
Efficacy of alcohol-based and alcohol-free melaleuca oral solution for the treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDSJose A Vazquez, Ahmad A ZawawiHIV Clinical Trials|December 14, 2001
Baseline antiretroviral drug susceptibility influences treatment response in patients receiving saquinavir-enhancing therapyT Middleton, D Smith, B Larder, et al.HIV Clinical Trials|December 14, 2001
Adherence to combination antiretroviral treatment in childrenE Pontali, M Feasi, F Toscanini, et al.HIV Clinical Trials|October 24, 2001
The use of efavirenz as a part of late rescue antiretroviral treatmentR Manfredi, E Rizzo, L Calza, et al.HIV Clinical Trials|October 24, 2001
Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapyM Núñez, P Saballs, M E Valencia, et al.HIV Clinical Trials|May 29, 2002
Prevalence of HIV co-receptor polymorphisms in HIV-infected patients and uninfected volunteers in LuxembourgFrançois Roman, Nathalie Franck, Catherine Burgy, et al.HIV Clinical Trials|October 9, 2001
Measuring adherence to antiretroviral medications in clinical trialsL G Miller, R D HaysHIV Clinical Trials|October 9, 2001
Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patientsJ A VazquezPageof 68